{"gene":"LAMB2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1989,"finding":"S-laminin (LAMB2) was identified as a laminin-like glycoprotein selectively concentrated in the synaptic cleft of the neuromuscular junction and recognized by motoneurons, establishing it as a synaptic basal lamina component that guides motor axon reinnervation.","method":"Protein purification, molecular cloning, immunolocalization at neuromuscular junctions","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — original discovery by reconstitution/cloning with functional validation, foundational paper with 550 citations","pmids":["2922051"],"is_preprint":false},{"year":1988,"finding":"The human laminin B2 (LAMB2) gene was chromosomally assigned to region 1q25–q31 using somatic cell hybrid hybridization and in situ hybridization, and a cDNA clone encoding the human laminin B2 chain was isolated and characterized.","method":"cDNA cloning, somatic cell hybrid panel hybridization, in situ hybridization","journal":"Cytogenetics and cell genetics","confidence":"High","confidence_rationale":"Tier 1 — direct experimental chromosomal mapping with multiple orthogonal methods","pmids":["3234037"],"is_preprint":false},{"year":1995,"finding":"The human LAMB2 gene was re-mapped to chromosome 3p21 (correcting the earlier 1q25 assignment from a different lab), and tissue-specific expression was established: LAMB2 (but not LAMB1) is expressed in fetal brain, renal glomeruli, bronchial epithelium, liver hepatocytes, and skin (both epidermal and dermal), while LAMB1 but not LAMB2 is expressed in striated muscle, demonstrating distinct biological roles for the two beta chains.","method":"Somatic cell hybrids, FISH, Northern blotting, in situ hybridization in multiple fetal tissues","journal":"Matrix biology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods establishing gene locus and tissue-specific expression pattern","pmids":["7795887"],"is_preprint":false},{"year":1994,"finding":"A new laminin nomenclature was adopted in which the former B2 chain (S-laminin) is designated the beta2 chain, and LAMB2 encodes the laminin beta2 subunit that assembles into heterotrimeric laminin isoforms (e.g., laminin-521).","method":"Nomenclature consensus/biochemical classification","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 3 — consensus nomenclature paper establishing protein identity within heterotrimers","pmids":["7921537"],"is_preprint":false},{"year":1999,"finding":"A detailed physical map of the LAMB2 locus on chromosome 3p21.3→p21.2 was generated, revealing that LAMB2 lies 16 kb from the glutaminyl tRNA synthetase gene (QARS) and ~20 kb downstream of a transcribed LAMB2-like pseudogene (LAMB2L), and that the locus is paralogous with the LAMB1 region on chromosome 7q22–q31.","method":"Genomic physical mapping, CpG island identification, microsatellite marker identification","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct genomic characterization with multiple markers establishing locus architecture","pmids":["10393422"],"is_preprint":false},{"year":2009,"finding":"Truncating heteroallelic LAMB2 mutations (1478delG and 4804delC) in a human patient caused a synaptic form of congenital myasthenic syndrome, with profound distortion of neuromuscular junction architecture: reduced axon terminal size, Schwann cell encasement of nerve endings, widened synaptic cleft, Schwann cell invasion of the synaptic space, simplified postsynaptic folds, and reduced endplate potential quantal content. Western blot and immunohistochemistry confirmed complete absence of laminin beta2 protein in muscle and kidney.","method":"Muscle biopsy histology and electron microscopy, electrophysiology (endplate potential recording, miniature endplate potential analysis), Western blot, immunohistochemistry, mutational analysis","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (electrophysiology, ultrastructure, protein expression) in human tissue establishing direct mechanistic role of LAMB2 at the neuromuscular junction","pmids":["19251977"],"is_preprint":false},{"year":2010,"finding":"Review and analysis of all known LAMB2 mutations revealed that truncating mutations are distributed across the entire gene and cause full loss of laminin beta2 function (Pierson syndrome), while missense mutations cluster in the N-terminal LN domain—which mediates intermolecular interactions—and are associated with milder/hypomorphic phenotypes, establishing genotype-phenotype correlations for the protein's functional domains.","method":"Mutational analysis across 39 families, genotype-phenotype correlation analysis","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 — large-scale genotype-phenotype correlation establishing functional importance of the LN domain for intermolecular interactions","pmids":["20556798"],"is_preprint":false},{"year":2011,"finding":"The R246Q missense mutation in LAMB2 causes nephrotic syndrome by impairing secretion of laminin-521 from podocytes into the glomerular basement membrane (GBM). In vitro studies demonstrated impaired laminin secretion as the molecular defect; transgenic mice expressing R246Q-mutant rat laminin beta2 showed that increased expression of the mutant protein overcomes the secretion defect and improves glomerular permselectivity, with proteinuria severity inversely correlating with transgene expression level.","method":"Transgenic mouse generation (three lines), in vitro laminin secretion assay, proteinuria measurement, immunolocalization, electron microscopy, slit diaphragm protein localization","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 1 — in vitro secretion assay plus multiple transgenic mouse lines with dose-response and ultrastructural readouts","pmids":["21511833"],"is_preprint":false},{"year":2012,"finding":"Mice homozygous null for laminin beta2 (Lamb2) and gamma3 (Lamc3) exhibit severe cortical laminar disorganization with hallmarks of cobblestone lissencephaly: fractured pial basement membrane, altered dystroglycan distribution, disrupted Cajal-Retzius cell distribution, altered radial glial morphology, ectopic germinal zones, and midline fusion. Heterozygous mice also show laminar disruption, demonstrating a dose-dependent role for beta2/gamma3-containing laminins in cortical pial basement membrane integrity.","method":"Lamb2/Lamc3 double knockout mice, cortical histology, immunofluorescence (dystroglycan, Cajal-Retzius cell markers, radial glial markers), comparison of homozygous and heterozygous phenotypes","journal":"Developmental neurobiology","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with multiple orthogonal histological readouts establishing dose-dependent role in cortical development","pmids":["22961762"],"is_preprint":false},{"year":2014,"finding":"A hypomorphic point mutation in mouse Lamb2 identified by ENU mutagenesis and next-generation sequencing causes a viable nephrotic phenotype, validating the glomerular filtration barrier role of LAMB2 in an animal model that recapitulates part of the human Pierson syndrome spectrum.","method":"ENU mutagenesis screen, whole-genome sequencing, renal phenotyping","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic in vivo model with sequencing-confirmed causative mutation and phenotypic characterization","pmids":["24293254"],"is_preprint":false},{"year":2020,"finding":"The lncRNA Airn binds to the RNA-binding protein Igf2bp2 and facilitates translation of Lamb2 (and Igf2) in podocytes, maintaining normal laminin beta2 levels and glomerular barrier function; Airn downregulation in high-glucose conditions reduces LAMB2 protein and impairs podocyte viability.","method":"RNA immunoprecipitation, RNA pull-down assay, lncRNA overexpression/knockdown, Western blot, cell viability assay","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 2-3 — RNA immunoprecipitation and pull-down establishing Airn-Igf2bp2-Lamb2 translational axis, single lab","pmids":["32437062"],"is_preprint":false},{"year":2022,"finding":"LAMB2 is abundant in exosomes secreted by oligodendrocyte precursor cells (OPCs) in response to astrocyte connexin 47 (Cx47) signaling; exogenous LAMB2 induces DNA replication in the S phase of OPCs by activating cyclin D1, promoting OPC proliferation.","method":"Cx47 siRNA knockdown, transcriptome sequencing, transmission electron microscopy, Western blot, nanoparticle tracking analysis, mass spectrometry of exosome content, exogenous LAMB2 administration, cell cycle analysis","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods identifying LAMB2 in exosomes and functional rescue with exogenous protein, single lab","pmids":["35596050"],"is_preprint":false},{"year":2024,"finding":"Under hypoxic conditions, ROCK1-mediated phosphorylation of Caveolin1 at Y14 promotes sorting of LAMB2 into extracellular vesicles derived from gastric cancer cells via activation of Rab11; extracellular vesicle-associated LAMB2 then promotes peritoneal metastasis in normoxic gastric cancer cells by activating the AKT pathway.","method":"Proteomic analysis, co-IP, phosphorylation assays, extracellular vesicle isolation, in vivo peritoneal metastasis models, pathway inhibition","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods (proteomics, co-IP, in vivo model) establishing ROCK1-CAV1-Rab11-LAMB2 mechanistic axis, single lab","pmids":["39138263"],"is_preprint":false},{"year":2021,"finding":"A novel LAMB2 intronic variant (c.2885-9C>A) was shown by minigene splicing assay to cause erroneous integration of a 7 bp sequence into intron 20, demonstrating a splicing mechanism by which non-canonical intronic variants disrupt laminin beta2 expression; immunohistochemistry confirmed absence of glomerular laminin beta2 protein in the affected patient.","method":"Minigene splicing assay, Sanger sequencing, immunohistochemistry","journal":"Molecular genetics & genomic medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional splicing assay with in vivo protein expression confirmation","pmids":["33982833"],"is_preprint":false}],"current_model":"LAMB2 encodes laminin beta2, a basement membrane protein that assembles into heterotrimeric laminin isoforms (e.g., laminin-521); it is selectively concentrated in synaptic clefts of the neuromuscular junction (where its loss disrupts NMJ architecture and quantal content), is essential for glomerular basement membrane integrity (missense mutations impair laminin secretion from podocytes, causing nephrotic syndrome), and supports cortical pial basement membrane assembly for radial glial and Cajal-Retzius cell guidance during brain development; its expression is post-transcriptionally regulated by the lncRNA Airn via Igf2bp2, and under hypoxia it is sorted into extracellular vesicles through ROCK1-phosphorylated Caveolin1/Rab11 to activate AKT-mediated metastatic signaling."},"narrative":{"teleology":[{"year":1988,"claim":"Chromosomal localization of LAMB2 provided the first genomic context for the gene, initially assigned to 1q25–q31 and later corrected to 3p21, establishing it as a distinct locus from LAMB1.","evidence":"cDNA cloning with somatic cell hybrid and FISH mapping across two independent studies","pmids":["3234037","7795887"],"confidence":"High","gaps":["Promoter and regulatory elements were not characterized","Evolutionary relationship to LAMB1 was only later addressed by physical mapping"]},{"year":1989,"claim":"Identification of S-laminin (LAMB2) as a synaptic cleft-specific laminin variant answered the question of how the neuromuscular junction basal lamina is molecularly distinct from extrasynaptic basement membrane.","evidence":"Protein purification, molecular cloning, and immunolocalization at neuromuscular junctions in frog and rat","pmids":["2922051"],"confidence":"High","gaps":["Mechanism of selective synaptic targeting was unknown","Functional consequences of loss at the NMJ were not yet tested"]},{"year":1995,"claim":"Tissue-specific expression profiling revealed that LAMB2 and LAMB1 have non-overlapping expression in many tissues (e.g., LAMB2 in glomeruli and brain, LAMB1 in striated muscle), establishing that the two beta chains fulfill distinct biological roles.","evidence":"Northern blot and in situ hybridization across human fetal tissues","pmids":["7795887"],"confidence":"High","gaps":["Functional significance of tissue-specific expression not yet tested by loss-of-function","Whether compensatory upregulation of LAMB1 occurs in LAMB2-deficient tissues was unknown"]},{"year":2009,"claim":"Analysis of a human patient with truncating LAMB2 mutations resolved the functional requirement for laminin beta-2 at the NMJ, showing that complete loss causes a synaptic congenital myasthenic syndrome with ultrastructural disruption and reduced quantal content.","evidence":"Human muscle biopsy with electron microscopy, electrophysiology (endplate potential and miniature endplate potential recording), Western blot, and mutation analysis","pmids":["19251977"],"confidence":"High","gaps":["Whether NMJ defects are secondary to developmental mis-patterning or ongoing structural maintenance failure was unclear","Mechanism by which laminin beta-2 organizes the postsynaptic apparatus was not defined"]},{"year":2010,"claim":"Systematic genotype-phenotype correlation across 39 families established that missense mutations cluster in the LN domain—the intermolecular interaction domain—and cause milder phenotypes, while truncating mutations throughout the gene cause severe Pierson syndrome, mapping functional criticality to the LN domain.","evidence":"Mutational analysis of 39 families with genotype-phenotype correlation","pmids":["20556798"],"confidence":"Medium","gaps":["No structural basis for why specific LN domain residues are critical","Contribution of other domains (e.g., coiled-coil) to function not systematically tested"]},{"year":2011,"claim":"The molecular mechanism of the R246Q missense mutation was resolved: it impairs secretion of laminin-521 from podocytes, and dose-dependent transgenic expression demonstrated that increasing mutant protein levels rescues glomerular permselectivity, establishing secretion efficiency as the rate-limiting step.","evidence":"In vitro laminin secretion assay, three transgenic mouse lines with graded expression, proteinuria measurement, immunolocalization, and electron microscopy","pmids":["21511833"],"confidence":"High","gaps":["Whether the secretion defect reflects misfolding or specific ER retention was not determined","Therapeutic strategies to boost secretion were not tested"]},{"year":2012,"claim":"Double knockout of Lamb2 and Lamc3 demonstrated a dose-dependent role for beta-2/gamma-3-containing laminins in maintaining the pial basement membrane, with loss causing cobblestone lissencephaly, disrupted Cajal-Retzius cell distribution, and radial glial detachment.","evidence":"Lamb2/Lamc3 single and double knockout mice with cortical histology, immunofluorescence for dystroglycan, Cajal-Retzius, and radial glial markers","pmids":["22961762"],"confidence":"High","gaps":["Individual contributions of LAMB2 versus LAMC3 to pial BM integrity were partially confounded by the double-knockout design","Downstream signaling through dystroglycan was correlative rather than causally tested"]},{"year":2020,"claim":"Identification of the lncRNA Airn/Igf2bp2 axis as a post-transcriptional regulator of LAMB2 translation in podocytes revealed how glomerular laminin beta-2 levels are maintained, with downregulation under high-glucose conditions linking LAMB2 to diabetic nephropathy pathogenesis.","evidence":"RNA immunoprecipitation, RNA pull-down, lncRNA overexpression/knockdown, Western blot in podocyte cell lines","pmids":["32437062"],"confidence":"Medium","gaps":["In vivo validation of the Airn-Igf2bp2-LAMB2 axis in animal models was not performed","Whether this regulatory axis operates outside podocytes was not tested"]},{"year":2022,"claim":"Discovery that LAMB2 is an abundant cargo of OPC-derived exosomes downstream of connexin 47 signaling, and that exogenous LAMB2 promotes OPC proliferation via cyclin D1 activation, extended LAMB2 function to paracrine signaling in glial biology.","evidence":"Mass spectrometry of exosome content, nanoparticle tracking, exogenous LAMB2 treatment with cell cycle analysis in OPCs","pmids":["35596050"],"confidence":"Medium","gaps":["The receptor or integrin through which extracellular LAMB2 activates cyclin D1 in OPCs was not identified","In vivo relevance for myelination or remyelination was not demonstrated"]},{"year":2024,"claim":"The ROCK1–phospho-Caveolin1(Y14)–Rab11 axis was identified as the mechanism by which hypoxic cancer cells sort LAMB2 into extracellular vesicles that activate AKT-dependent peritoneal metastasis, establishing a pathological gain-of-function role for LAMB2 in cancer.","evidence":"Proteomics, co-IP, phosphorylation assays, EV isolation, and in vivo peritoneal metastasis models in gastric cancer","pmids":["39138263"],"confidence":"Medium","gaps":["The receptor on recipient cells through which EV-associated LAMB2 activates AKT was not identified","Generalizability beyond gastric cancer was not addressed","Single-lab finding awaiting independent replication"]},{"year":null,"claim":"Key unresolved questions include the structural basis for LN domain missense mutation pathogenicity, the receptor(s) mediating extracellular LAMB2 signaling on OPCs and cancer cells, whether ER chaperone-assisted strategies can rescue secretion-deficient mutants therapeutically, and the relative individual contributions of LAMB2 versus LAMC3 to pial basement membrane integrity.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of laminin beta-2 LN domain","No identified receptor for paracrine/EV-mediated LAMB2 signaling","No therapeutic rescue of secretion-deficient mutants demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,5,8]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,5,8]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,5,7,8]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,7,11,12]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[11,12]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,5,7,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[11,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,7,12]}],"complexes":["Laminin-521 heterotrimer"],"partners":["LAMA5","LAMC1","LAMC3","IGF2BP2","CAV1","RAB11A","ROCK1"],"other_free_text":[]},"mechanistic_narrative":"LAMB2 encodes laminin subunit beta-2, a basement membrane glycoprotein that assembles into heterotrimeric laminin isoforms (e.g., laminin-521) and is essential for structural integrity at the neuromuscular junction, glomerular filtration barrier, and cortical pial surface [PMID:2922051, PMID:21511833, PMID:22961762]. At the neuromuscular junction, laminin beta-2 concentrates in the synaptic cleft where it organizes pre- and postsynaptic architecture; its complete absence causes a congenital myasthenic syndrome with reduced quantal content, simplified postsynaptic folds, and Schwann cell invasion of the synaptic space [PMID:19251977]. In the kidney, disease-causing missense mutations—clustered in the N-terminal LN domain—impair laminin-521 secretion from podocytes, resulting in glomerular basement membrane defects and nephrotic syndrome (Pierson syndrome), with severity inversely proportional to residual secretion [PMID:21511833, PMID:20556798]. LAMB2 translation in podocytes is post-transcriptionally regulated by the lncRNA Airn via Igf2bp2, and under hypoxia LAMB2 is sorted into extracellular vesicles through ROCK1-phosphorylated Caveolin-1/Rab11 to activate AKT signaling in recipient cells [PMID:32437062, PMID:39138263]."},"prefetch_data":{"uniprot":{"accession":"P55268","full_name":"Laminin subunit beta-2","aliases":["Laminin B1s chain","Laminin-11 subunit beta","Laminin-14 subunit beta","Laminin-15 subunit beta","Laminin-3 subunit beta","Laminin-4 subunit beta","Laminin-7 subunit beta","Laminin-9 subunit beta","S-laminin subunit beta","S-LAM beta"],"length_aa":1798,"mass_kda":196.0,"function":"Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components","subcellular_location":"Secreted, extracellular space, extracellular matrix, basement membrane","url":"https://www.uniprot.org/uniprotkb/P55268/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LAMB2","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/LAMB2","total_profiled":1310},"omim":[{"mim_id":"617609","title":"NEPHROTIC SYNDROME, TYPE 15; NPHS15","url":"https://www.omim.org/entry/617609"},{"mim_id":"614199","title":"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5","url":"https://www.omim.org/entry/614199"},{"mim_id":"610725","title":"NEPHROTIC SYNDROME, TYPE 3; NPHS3","url":"https://www.omim.org/entry/610725"},{"mim_id":"609049","title":"PIERSON SYNDROME; PIERS","url":"https://www.omim.org/entry/609049"},{"mim_id":"606382","title":"MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2","url":"https://www.omim.org/entry/606382"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LAMB2"},"hgnc":{"alias_symbol":["NPHS5"],"prev_symbol":["LAMS"]},"alphafold":{"accession":"P11047","domains":[{"cath_id":"2.60.120.260","chopping":"55-288","consensus_level":"high","plddt":88.8962,"start":55,"end":288},{"cath_id":"2.10.25.10","chopping":"291-360","consensus_level":"medium","plddt":88.4943,"start":291,"end":360},{"cath_id":"2.170.300.10","chopping":"373-445","consensus_level":"high","plddt":83.6314,"start":373,"end":445},{"cath_id":"2.170.300.10","chopping":"448-495","consensus_level":"medium","plddt":84.409,"start":448,"end":495},{"cath_id":"2.60.120.260","chopping":"507-689","consensus_level":"high","plddt":86.8161,"start":507,"end":689},{"cath_id":"2.10.25.10","chopping":"693-780","consensus_level":"medium","plddt":82.7682,"start":693,"end":780}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11047","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11047-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11047-F1-predicted_aligned_error_v6.png","plddt_mean":76.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LAMB2","jax_strain_url":"https://www.jax.org/strain/search?query=LAMB2"},"sequence":{"accession":"P11047","fasta_url":"https://rest.uniprot.org/uniprotkb/P11047.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11047/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11047"}},"corpus_meta":[{"pmid":"17371932","id":"PMC_17371932","title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).","date":"2007","source":"Pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/17371932","citation_count":313,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20556798","id":"PMC_20556798","title":"Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20556798","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16912710","id":"PMC_16912710","title":"Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16912710","citation_count":136,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19251977","id":"PMC_19251977","title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19251977","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22961762","id":"PMC_22961762","title":"β2 and γ3 laminins are critical cortical basement membrane components: ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia.","date":"2012","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22961762","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16101165","id":"PMC_16101165","title":"Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.","date":"2005","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16101165","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21511833","id":"PMC_21511833","title":"A missense LAMB2 mutation causes congenital nephrotic syndrome by impairing laminin secretion.","date":"2011","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/21511833","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16921188","id":"PMC_16921188","title":"A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused by mutated LAMB2.","date":"2006","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/16921188","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7795887","id":"PMC_7795887","title":"The human laminin beta 2 chain (S-laminin): structure, expression in fetal tissues and chromosomal assignment of the LAMB2 gene.","date":"1995","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/7795887","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21236492","id":"PMC_21236492","title":"A novel mutation of LAMB2 in a multigenerational mennonite family reveals a new phenotypic variant of Pierson syndrome.","date":"2011","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21236492","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19908064","id":"PMC_19908064","title":"Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.","date":"2009","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19908064","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3234037","id":"PMC_3234037","title":"Isolation of a human laminin B2 (LAMB2) cDNA clone and assignment of the gene to chromosome region 1q25----q31.","date":"1988","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3234037","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32437062","id":"PMC_32437062","title":"Long noncoding RNA Airn protects podocytes from diabetic nephropathy lesions via binding to Igf2bp2 and facilitating translation of Igf2 and Lamb2.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/32437062","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19861315","id":"PMC_19861315","title":"The first Chinese Pierson syndrome with novel mutations in LAMB2.","date":"2009","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/19861315","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35596050","id":"PMC_35596050","title":"Astrocytes promote the proliferation of oligodendrocyte precursor cells through connexin 47-mediated LAMB2 secretion in exosomes.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35596050","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24856380","id":"PMC_24856380","title":"Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.","date":"2014","source":"Bosnian journal of basic medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24856380","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27130041","id":"PMC_27130041","title":"A novel LAMB2 gene mutation associated with a severe phenotype in a neonate with Pierson syndrome.","date":"2016","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/27130041","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30013592","id":"PMC_30013592","title":"Screening of the LAMB2, WT1, NPHS1, and NPHS2 Genes in Pediatric Nephrotic Syndrome.","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30013592","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28188379","id":"PMC_28188379","title":"A novel mutation of laminin β2 (LAMB2) in two siblings with renal failure.","date":"2017","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/28188379","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39138263","id":"PMC_39138263","title":"Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis.","date":"2024","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/39138263","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31769495","id":"PMC_31769495","title":"Mutations in LAMB2 Are Associated With Albuminuria and Optic Nerve Hypoplasia With Hypopituitarism.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31769495","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27004562","id":"PMC_27004562","title":"Simultaneous mutations of LAMB2 and NPHP1genes in a Chinese girl with isolated congenital nephrotic syndrome: a case report.","date":"2016","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27004562","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1675982","id":"PMC_1675982","title":"The gene for retinal rod 33-kDa protein is on mouse chromosome 1, near Lamb2.","date":"1991","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1675982","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28683731","id":"PMC_28683731","title":"Nephron development and extrarenal features in a child with congenital nephrotic syndrome caused by null LAMB2 mutations.","date":"2017","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/28683731","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20093232","id":"PMC_20093232","title":"Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS study.","date":"2010","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20093232","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27925579","id":"PMC_27925579","title":"LAMB2 mutation with different phenotypes in China
.","date":"2017","source":"Clinical nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/27925579","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30778388","id":"PMC_30778388","title":"A Novel Homozygous Truncating Mutation in LAMB2 Gene in a Chinese Uyghur Patient With Severe Phenotype Pierson Syndrome.","date":"2019","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30778388","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24293254","id":"PMC_24293254","title":"Next-generation sequencing to dissect hereditary nephrotic syndrome in mice identifies a hypomorphic mutation in Lamb2 and models Pierson's syndrome.","date":"2014","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24293254","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10393422","id":"PMC_10393422","title":"Characterization of the human laminin beta2 chain locus (LAMB2): linkage to a gene containing a nonprocessed, transcribed LAMB2-like pseudogene (LAMB2L) and to the gene encoding glutaminyl tRNA synthetase (QARS).","date":"1999","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10393422","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37678612","id":"PMC_37678612","title":"Early-Onset Myopia and Retinal Detachment without Typical Microcoria or Severe Proteinuria due to a Novel LAMB2 Variant.","date":"2023","source":"Ophthalmology. Retina","url":"https://pubmed.ncbi.nlm.nih.gov/37678612","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39386558","id":"PMC_39386558","title":"Identification of conserved and tissue-restricted transcriptional profiles for lipid associated macrophages (LAMs).","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39386558","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34546508","id":"PMC_34546508","title":"Mutational landscape of TRPC6, WT1, LMX1B, APOL1, PTPRO, PMM2, LAMB2 and WT1 genes associated with Steroid resistant nephrotic syndrome.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/34546508","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16898484","id":"PMC_16898484","title":"[LAMB2 gene mutation as a cause of congenital nephrotic syndrome with distinct eye abnormalities and hypotonia].","date":"2006","source":"Przeglad lekarski","url":"https://pubmed.ncbi.nlm.nih.gov/16898484","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38038886","id":"PMC_38038886","title":"LAMB2 gene: broad clinical spectrum in Pierson syndrome.","date":"2023","source":"CEN case reports","url":"https://pubmed.ncbi.nlm.nih.gov/38038886","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38723581","id":"PMC_38723581","title":"Expanding the spectrum of LAMB2: Pierson syndrome associated with neuromuscular junction disorder in two patients.","date":"2024","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/38723581","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40826341","id":"PMC_40826341","title":"How does LAMB2 contribute to kidney disease? Insights from a pediatric case.","date":"2025","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/40826341","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39416865","id":"PMC_39416865","title":"The clinical characteristics and genotype analysis of LAMB2 gene mutation.","date":"2024","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39416865","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33476040","id":"PMC_33476040","title":"An extremely mild clinical course in a case with LAMB2-associated nephritis diagnosed with next-generation sequencing.","date":"2021","source":"CEN case reports","url":"https://pubmed.ncbi.nlm.nih.gov/33476040","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33982833","id":"PMC_33982833","title":"LAMB2 novel variant c.2885-9 C>A affects RNA splicing in a minigene assay.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33982833","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40875165","id":"PMC_40875165","title":"Preservation of EUS-guided gastrojejunostomy LAMS during pancreaticoduodenectomy: a paradigm shift in the surgical management of borderline resectable pancreatic cancer.","date":"2025","source":"Updates in surgery","url":"https://pubmed.ncbi.nlm.nih.gov/40875165","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.25.678284","title":"Adipose tissue cell states linked to progression and clinical subtypes of MASLD in human obesity","date":"2025-09-29","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.25.678284","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.24.661397","title":"Bacteriophages target membrane-anchored glycopolymers to promote host cell lysis and progeny release","date":"2025-06-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.24.661397","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.15.670462","title":"Mapping Leukocyte Dynamics during Neuroinflammation Identifies Meningeal Monocyte-Derived Macrophages as Drivers of Progressive Disease","date":"2025-08-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.15.670462","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.26.25321148","title":"Surface Electromyographic Assessment of Pelvic Floor Muscles Protocol Tested by a Novel Airbag-type Stretchable Electrode Array (ASEA) Device in Stress Urinary Incontinence in Postmenopausal Women","date":"2025-01-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.26.25321148","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.11.25335560","title":"Effects of butyrylated high amylose maize starch (HAMSB) as an adjuvant for oral immunotherapy","date":"2025-09-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.11.25335560","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.07.29.605588","title":"MACanalyzeR: scRNA-seq Analysis Tool Reveals PPARγHI Lipid-Associated Macrophages Facilitate Thermogenic Expansion in BAT","date":"2024-07-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.29.605588","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.28.635153","title":"sciLaMA: A Single-Cell Representation Learning Framework to Leverage Prior Knowledge from Large Language Models","date":"2025-02-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.28.635153","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.10.12.618004","title":"Nerve-associated macrophages control adipose homeostasis across lifespan and restrain age-related inflammation","date":"2024-10-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.12.618004","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30280653","id":"PMC_30280653","title":"Blood-Brain Barrier: From Physiology to Disease and Back.","date":"2019","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30280653","citation_count":1645,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12754519","id":"PMC_12754519","title":"Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12754519","citation_count":1176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21421915","id":"PMC_21421915","title":"Basement membranes: cell scaffoldings and signaling platforms.","date":"2011","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/21421915","citation_count":720,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7921537","id":"PMC_7921537","title":"A new nomenclature for the laminins.","date":"1994","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/7921537","citation_count":716,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2922051","id":"PMC_2922051","title":"A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2922051","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9885251","id":"PMC_9885251","title":"Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9885251","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3109910","id":"PMC_3109910","title":"Laminin-nidogen complex. Extraction with chelating agents and structural characterization.","date":"1987","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3109910","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11683410","id":"PMC_11683410","title":"Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11683410","citation_count":333,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23057746","id":"PMC_23057746","title":"Functional diversity of laminins.","date":"2012","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23057746","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32322062","id":"PMC_32322062","title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32322062","citation_count":292,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23266556","id":"PMC_23266556","title":"Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.","date":"2012","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23266556","citation_count":283,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11054877","id":"PMC_11054877","title":"Integrins as receptors for laminins.","date":"2000","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/11054877","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15231748","id":"PMC_15231748","title":"Functional proteomics mapping of a human signaling pathway.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15231748","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24826,"output_tokens":3232,"usd":0.061479},"stage2":{"model":"claude-opus-4-6","input_tokens":6631,"output_tokens":3076,"usd":0.165082},"total_usd":0.469737,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":37267,"output_tokens":3467,"usd":0.081903},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7098,"output_tokens":2881,"usd":0.161273}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"The human laminin β2 chain (LAMB2) was cloned and shown to encode a 1798-amino acid protein with a 32-residue signal peptide; tissue-specific expression was demonstrated by in situ hybridization showing β2 (but not β1) expression in fetal brain, renal glomeruli, bronchial epithelial cells, and hepatocytes, establishing distinct biological roles for the two beta chains.\",\n      \"method\": \"cDNA cloning, Northern blot, in situ hybridization, chromosomal localization by somatic cell hybrids and FISH\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original molecular characterization with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"7795887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"LAMB2 (then called laminin B2) was identified as one of the three polypeptide chains of laminin, a basement membrane glycoprotein, and the gene was assigned to chromosome 1q25–q31 (later corrected to 3p21).\",\n      \"method\": \"cDNA cloning, somatic cell hybrid hybridization, in situ hybridization to metaphase chromosomes\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original gene isolation and chromosomal assignment with direct molecular methods\",\n      \"pmids\": [\"3234037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"LAMB2 was mapped to chromosome 3p21.3→p21.2 in a 110-kb genomic segment; LAMB2 lies 16 kb from the glutaminyl tRNA synthetase gene (QARS) and ~20 kb downstream of a transcribed LAMB2-like pseudogene (LAMB2L), establishing the genomic organization of the locus.\",\n      \"method\": \"Physical mapping, CpG island identification, microsatellite marker identification, sequence analysis\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — detailed physical map from a single study using multiple molecular methods\",\n      \"pmids\": [\"10393422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss-of-function LAMB2 mutations (frameshift heteroallelic 1478delG and 4804delC) in humans cause a severe synaptic congenital myasthenic syndrome with profound distortion of neuromuscular junction architecture: reduced axon terminal size, Schwann cell encasement of nerve endings, widened primary synaptic cleft, Schwann cell invasion of the synaptic space, simplified postsynaptic folds, reduced endplate potential quantal content, and absent laminin β2 protein by Western blot and immunohistochemistry—mirroring the phenotype of Lamb2-null mice.\",\n      \"method\": \"Mutational analysis, muscle biopsy histology/electron microscopy, Western blot, immunohistochemistry, electrophysiology (endplate potential recording, miniature endplate potential analysis)\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods in patient tissue establishing direct role of LAMB2 in NMJ architecture and function\",\n      \"pmids\": [\"19251977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The missense mutation R246Q in LAMB2 causes nephrotic syndrome by impairing secretion of laminin-521 from podocytes into the glomerular basement membrane (GBM); in vitro studies demonstrated impaired laminin secretion, and transgenic rescue showed that higher expression of the mutant protein overcomes the secretion defect and improves glomerular permselectivity.\",\n      \"method\": \"Transgenic mouse rescue (R246Q-mutant rat LAMB2 replacing mouse LAMB2), in vitro laminin secretion assay, proteinuria measurement, immunofluorescence, electron microscopy\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro secretion assay plus transgenic animal model with dose-response relationship and multiple orthogonal readouts\",\n      \"pmids\": [\"21511833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Laminin β2 (encoded by Lamb2) is a critical component of the cortical pial basement membrane; mice null for Lamb2 (combined with Lamc3 null) exhibit severe cortical laminar disorganization, midline fusion, perturbed Cajal-Retzius cell distribution, altered radial glial morphology, fractured pial basement membrane, and altered dystroglycan distribution—hallmarks of cobblestone lissencephaly; heterozygous mice also show laminar disruption, indicating a dose-dependent role.\",\n      \"method\": \"Conditional/constitutive knockout mouse model (Lamb2-null, Lamc3-null, compound null), histology, immunofluorescence for dystroglycan and Cajal-Retzius markers, radial glial morphology analysis\",\n      \"journal\": \"Developmental neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with multiple orthogonal phenotypic readouts, dose-dependent effect confirmed in heterozygotes\",\n      \"pmids\": [\"22961762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Missense mutations in LAMB2 cluster in the N-terminal LN domain, which is critical for intermolecular interactions; truncating mutations distributed across the entire gene cause complete loss of laminin β2 function, while missense and small in-frame deletions (likely hypomorphic alleles) associate with milder phenotypes and later onset of renal disease.\",\n      \"method\": \"Comprehensive mutational analysis across 39 families, genotype-phenotype correlation, protein domain mapping\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — large cohort genotype-phenotype analysis; mechanistic inference from domain clustering of mutations supported by preponderance of evidence across labs\",\n      \"pmids\": [\"20556798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A hypomorphic ENU-induced point mutation in mouse Lamb2 identified by whole-genome sequencing causes a viable nephrotic phenotype, establishing Lamb2 as required for glomerular permeability and providing a model for partial-loss-of-function spectrum of Pierson syndrome.\",\n      \"method\": \"ENU mutagenesis, whole-genome sequencing, renal phenotyping\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function model with genetic identification, single study\",\n      \"pmids\": [\"24293254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The lncRNA Airn binds to the RNA-binding protein Igf2bp2 (demonstrated by RNA immunoprecipitation and RNA pull-down), and this interaction facilitates translation of both Igf2 and Lamb2, thereby maintaining podocyte viability and glomerular barrier function; Airn knockdown reduces LAMB2 protein levels and worsens podocyte survival under high-glucose conditions.\",\n      \"method\": \"RNA immunoprecipitation, RNA pull-down, lncRNA overexpression/knockdown, Western blot for LAMB2 protein, cell viability and apoptosis assays\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding demonstrated by RNA-IP and pull-down with functional consequence on LAMB2 translation; single lab\",\n      \"pmids\": [\"32437062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LAMB2 protein is secreted in exosomes from oligodendrocyte precursor cells (OPCs) in an astrocyte-dependent manner via Connexin 47 (Cx47)-mediated signaling; exosome-associated LAMB2 promotes OPC proliferation by activating cyclin D1 and driving S-phase entry.\",\n      \"method\": \"siRNA knockdown of Cx47, transcriptome sequencing, transmission electron microscopy, Western blot, nanoparticle tracking analysis, mass spectrometry of exosome contents, exogenous LAMB2 administration, cell cycle analysis\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mass spectrometry identification plus functional rescue with exogenous LAMB2 and cyclin D1 readout; single lab\",\n      \"pmids\": [\"35596050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In gastric cancer cells, hypoxia drives ROCK1-mediated phosphorylation of Caveolin1 at Y14, which facilitates sorting of LAMB2 into extracellular vesicles; EVs carrying LAMB2 then promote peritoneal metastasis in normoxic gastric cancer cells by activating the AKT pathway. Caveolin1 plays a central role in mediating LAMB2 loading into EVs, and Rab11 is activated downstream of Y14-phosphorylated Caveolin1 to enhance this sorting.\",\n      \"method\": \"Proteomic analysis of EVs, knockdown/overexpression experiments, phosphorylation site mutagenesis (Y14), Rab11 activation assays, AKT pathway activation assays, peritoneal metastasis mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mechanistic experiments (proteomics, mutagenesis, pathway activation) in a single lab study\",\n      \"pmids\": [\"39138263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A novel LAMB2 intronic variant (c.2885-9C>A) was shown by minigene splicing assay to cause erroneous integration of a 7-bp sequence into intron 20, resulting in aberrant splicing; immunohistochemistry of patient kidney tissue showed absent glomerular laminin β2 expression, confirming pathogenic loss of function.\",\n      \"method\": \"Minigene splicing assay, Sanger sequencing, immunohistochemistry\",\n      \"journal\": \"Molecular genetics & genomic medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional splicing assay with direct protein expression confirmation in patient tissue\",\n      \"pmids\": [\"33982833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Laminin β2 is expressed during pituitary development, and Lamb2-null mice exhibit abnormal anterior pituitary gland parenchyma in addition to stunted growth and abnormal neural retinae, establishing a role for LAMB2 in pituitary gland development.\",\n      \"method\": \"Lamb2 knockout mouse histological analysis of anterior pituitary, growth measurements, retinal analysis\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mouse knockout observation reported as part of a clinical case report, limited methodological detail\",\n      \"pmids\": [\"31769495\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LAMB2 encodes laminin β2, a secreted basement membrane protein that is incorporated into heterotrimeric laminin isoforms (e.g., laminin-521) essential for the glomerular basement membrane, neuromuscular junction, cortical pial basement membrane, and pituitary; its N-terminal LN domain mediates intermolecular interactions for laminin polymerization, loss-of-function mutations abolish laminin secretion from podocytes and disrupt NMJ architecture (reducing quantal content and inducing Schwann cell invasion), and at the cellular level LAMB2-containing extracellular vesicles activate AKT and cyclin D1 to drive proliferation, while its translation is regulated by the lncRNA Airn via the RNA-binding protein Igf2bp2.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"S-laminin (LAMB2) was identified as a laminin-like glycoprotein selectively concentrated in the synaptic cleft of the neuromuscular junction and recognized by motoneurons, establishing it as a synaptic basal lamina component that guides motor axon reinnervation.\",\n      \"method\": \"Protein purification, molecular cloning, immunolocalization at neuromuscular junctions\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original discovery by reconstitution/cloning with functional validation, foundational paper with 550 citations\",\n      \"pmids\": [\"2922051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The human laminin B2 (LAMB2) gene was chromosomally assigned to region 1q25–q31 using somatic cell hybrid hybridization and in situ hybridization, and a cDNA clone encoding the human laminin B2 chain was isolated and characterized.\",\n      \"method\": \"cDNA cloning, somatic cell hybrid panel hybridization, in situ hybridization\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct experimental chromosomal mapping with multiple orthogonal methods\",\n      \"pmids\": [\"3234037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The human LAMB2 gene was re-mapped to chromosome 3p21 (correcting the earlier 1q25 assignment from a different lab), and tissue-specific expression was established: LAMB2 (but not LAMB1) is expressed in fetal brain, renal glomeruli, bronchial epithelium, liver hepatocytes, and skin (both epidermal and dermal), while LAMB1 but not LAMB2 is expressed in striated muscle, demonstrating distinct biological roles for the two beta chains.\",\n      \"method\": \"Somatic cell hybrids, FISH, Northern blotting, in situ hybridization in multiple fetal tissues\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods establishing gene locus and tissue-specific expression pattern\",\n      \"pmids\": [\"7795887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"A new laminin nomenclature was adopted in which the former B2 chain (S-laminin) is designated the beta2 chain, and LAMB2 encodes the laminin beta2 subunit that assembles into heterotrimeric laminin isoforms (e.g., laminin-521).\",\n      \"method\": \"Nomenclature consensus/biochemical classification\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — consensus nomenclature paper establishing protein identity within heterotrimers\",\n      \"pmids\": [\"7921537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A detailed physical map of the LAMB2 locus on chromosome 3p21.3→p21.2 was generated, revealing that LAMB2 lies 16 kb from the glutaminyl tRNA synthetase gene (QARS) and ~20 kb downstream of a transcribed LAMB2-like pseudogene (LAMB2L), and that the locus is paralogous with the LAMB1 region on chromosome 7q22–q31.\",\n      \"method\": \"Genomic physical mapping, CpG island identification, microsatellite marker identification\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct genomic characterization with multiple markers establishing locus architecture\",\n      \"pmids\": [\"10393422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Truncating heteroallelic LAMB2 mutations (1478delG and 4804delC) in a human patient caused a synaptic form of congenital myasthenic syndrome, with profound distortion of neuromuscular junction architecture: reduced axon terminal size, Schwann cell encasement of nerve endings, widened synaptic cleft, Schwann cell invasion of the synaptic space, simplified postsynaptic folds, and reduced endplate potential quantal content. Western blot and immunohistochemistry confirmed complete absence of laminin beta2 protein in muscle and kidney.\",\n      \"method\": \"Muscle biopsy histology and electron microscopy, electrophysiology (endplate potential recording, miniature endplate potential analysis), Western blot, immunohistochemistry, mutational analysis\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (electrophysiology, ultrastructure, protein expression) in human tissue establishing direct mechanistic role of LAMB2 at the neuromuscular junction\",\n      \"pmids\": [\"19251977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Review and analysis of all known LAMB2 mutations revealed that truncating mutations are distributed across the entire gene and cause full loss of laminin beta2 function (Pierson syndrome), while missense mutations cluster in the N-terminal LN domain—which mediates intermolecular interactions—and are associated with milder/hypomorphic phenotypes, establishing genotype-phenotype correlations for the protein's functional domains.\",\n      \"method\": \"Mutational analysis across 39 families, genotype-phenotype correlation analysis\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — large-scale genotype-phenotype correlation establishing functional importance of the LN domain for intermolecular interactions\",\n      \"pmids\": [\"20556798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The R246Q missense mutation in LAMB2 causes nephrotic syndrome by impairing secretion of laminin-521 from podocytes into the glomerular basement membrane (GBM). In vitro studies demonstrated impaired laminin secretion as the molecular defect; transgenic mice expressing R246Q-mutant rat laminin beta2 showed that increased expression of the mutant protein overcomes the secretion defect and improves glomerular permselectivity, with proteinuria severity inversely correlating with transgene expression level.\",\n      \"method\": \"Transgenic mouse generation (three lines), in vitro laminin secretion assay, proteinuria measurement, immunolocalization, electron microscopy, slit diaphragm protein localization\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro secretion assay plus multiple transgenic mouse lines with dose-response and ultrastructural readouts\",\n      \"pmids\": [\"21511833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mice homozygous null for laminin beta2 (Lamb2) and gamma3 (Lamc3) exhibit severe cortical laminar disorganization with hallmarks of cobblestone lissencephaly: fractured pial basement membrane, altered dystroglycan distribution, disrupted Cajal-Retzius cell distribution, altered radial glial morphology, ectopic germinal zones, and midline fusion. Heterozygous mice also show laminar disruption, demonstrating a dose-dependent role for beta2/gamma3-containing laminins in cortical pial basement membrane integrity.\",\n      \"method\": \"Lamb2/Lamc3 double knockout mice, cortical histology, immunofluorescence (dystroglycan, Cajal-Retzius cell markers, radial glial markers), comparison of homozygous and heterozygous phenotypes\",\n      \"journal\": \"Developmental neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with multiple orthogonal histological readouts establishing dose-dependent role in cortical development\",\n      \"pmids\": [\"22961762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A hypomorphic point mutation in mouse Lamb2 identified by ENU mutagenesis and next-generation sequencing causes a viable nephrotic phenotype, validating the glomerular filtration barrier role of LAMB2 in an animal model that recapitulates part of the human Pierson syndrome spectrum.\",\n      \"method\": \"ENU mutagenesis screen, whole-genome sequencing, renal phenotyping\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic in vivo model with sequencing-confirmed causative mutation and phenotypic characterization\",\n      \"pmids\": [\"24293254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The lncRNA Airn binds to the RNA-binding protein Igf2bp2 and facilitates translation of Lamb2 (and Igf2) in podocytes, maintaining normal laminin beta2 levels and glomerular barrier function; Airn downregulation in high-glucose conditions reduces LAMB2 protein and impairs podocyte viability.\",\n      \"method\": \"RNA immunoprecipitation, RNA pull-down assay, lncRNA overexpression/knockdown, Western blot, cell viability assay\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RNA immunoprecipitation and pull-down establishing Airn-Igf2bp2-Lamb2 translational axis, single lab\",\n      \"pmids\": [\"32437062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LAMB2 is abundant in exosomes secreted by oligodendrocyte precursor cells (OPCs) in response to astrocyte connexin 47 (Cx47) signaling; exogenous LAMB2 induces DNA replication in the S phase of OPCs by activating cyclin D1, promoting OPC proliferation.\",\n      \"method\": \"Cx47 siRNA knockdown, transcriptome sequencing, transmission electron microscopy, Western blot, nanoparticle tracking analysis, mass spectrometry of exosome content, exogenous LAMB2 administration, cell cycle analysis\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods identifying LAMB2 in exosomes and functional rescue with exogenous protein, single lab\",\n      \"pmids\": [\"35596050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Under hypoxic conditions, ROCK1-mediated phosphorylation of Caveolin1 at Y14 promotes sorting of LAMB2 into extracellular vesicles derived from gastric cancer cells via activation of Rab11; extracellular vesicle-associated LAMB2 then promotes peritoneal metastasis in normoxic gastric cancer cells by activating the AKT pathway.\",\n      \"method\": \"Proteomic analysis, co-IP, phosphorylation assays, extracellular vesicle isolation, in vivo peritoneal metastasis models, pathway inhibition\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods (proteomics, co-IP, in vivo model) establishing ROCK1-CAV1-Rab11-LAMB2 mechanistic axis, single lab\",\n      \"pmids\": [\"39138263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A novel LAMB2 intronic variant (c.2885-9C>A) was shown by minigene splicing assay to cause erroneous integration of a 7 bp sequence into intron 20, demonstrating a splicing mechanism by which non-canonical intronic variants disrupt laminin beta2 expression; immunohistochemistry confirmed absence of glomerular laminin beta2 protein in the affected patient.\",\n      \"method\": \"Minigene splicing assay, Sanger sequencing, immunohistochemistry\",\n      \"journal\": \"Molecular genetics & genomic medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional splicing assay with in vivo protein expression confirmation\",\n      \"pmids\": [\"33982833\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LAMB2 encodes laminin beta2, a basement membrane protein that assembles into heterotrimeric laminin isoforms (e.g., laminin-521); it is selectively concentrated in synaptic clefts of the neuromuscular junction (where its loss disrupts NMJ architecture and quantal content), is essential for glomerular basement membrane integrity (missense mutations impair laminin secretion from podocytes, causing nephrotic syndrome), and supports cortical pial basement membrane assembly for radial glial and Cajal-Retzius cell guidance during brain development; its expression is post-transcriptionally regulated by the lncRNA Airn via Igf2bp2, and under hypoxia it is sorted into extracellular vesicles through ROCK1-phosphorylated Caveolin1/Rab11 to activate AKT-mediated metastatic signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LAMB2 encodes the laminin β2 chain, a secreted basement membrane glycoprotein that assembles into heterotrimeric laminin isoforms (e.g., laminin-521) essential for structural integrity and signaling at the glomerular basement membrane, neuromuscular junction, cortical pial surface, and developing pituitary [PMID:7795887, PMID:21511833, PMID:22961762, PMID:31769495]. The N-terminal LN domain mediates laminin polymerization, and missense mutations clustering in this domain impair secretion of laminin-521 from podocytes, causing nephrotic syndrome (Pierson syndrome), while truncating mutations throughout the gene abolish protein function entirely [PMID:20556798, PMID:21511833]. Loss-of-function LAMB2 mutations in humans cause congenital myasthenic syndrome with profoundly disrupted neuromuscular junction architecture—including reduced quantal content, Schwann cell invasion of the synaptic cleft, and simplified postsynaptic folds—mirroring phenotypes in Lamb2-null mice [PMID:19251977]. Beyond its structural role, LAMB2 is sorted into extracellular vesicles via ROCK1/Caveolin1-dependent mechanisms and can activate AKT signaling and cyclin D1-driven proliferation in recipient cells, while its translation in podocytes is regulated by the lncRNA Airn through the RNA-binding protein Igf2bp2 [PMID:39138263, PMID:35596050, PMID:32437062].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Identification of LAMB2 as a distinct laminin chain gene with chromosomal assignment established that multiple laminin β chains exist and occupy separate genomic loci, opening investigation of chain-specific functions.\",\n      \"evidence\": \"cDNA cloning and somatic cell hybrid/in situ hybridization mapping in human cells\",\n      \"pmids\": [\"3234037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromosomal assignment was initially incorrect (1q25–q31, later revised to 3p21)\", \"No functional distinction between β1 and β2 chains demonstrated\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Full-length cloning of LAMB2 and tissue-specific expression profiling revealed that β2 and β1 chains are expressed in distinct tissues (β2 in glomeruli, fetal brain, hepatocytes), establishing that laminin β chains have non-redundant biological roles.\",\n      \"evidence\": \"cDNA cloning, Northern blot, in situ hybridization of human fetal and adult tissues\",\n      \"pmids\": [\"7795887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional data on β2-containing laminin trimers\", \"Protein-level confirmation of tissue specificity not performed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Detailed physical mapping placed LAMB2 at 3p21.3→p21.2 adjacent to QARS and a pseudogene, resolving the genomic organization and correcting earlier chromosomal assignments.\",\n      \"evidence\": \"Physical mapping, CpG island and microsatellite identification\",\n      \"pmids\": [\"10393422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No regulatory element annotation\", \"Functional significance of pseudogene LAMB2L unexplored\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that human LAMB2 loss-of-function mutations cause congenital myasthenic syndrome with grossly disrupted NMJ ultrastructure and reduced quantal content established LAMB2 as a structural organizer of the synaptic basal lamina, not merely a passive matrix component.\",\n      \"evidence\": \"Mutational analysis, patient muscle biopsy electron microscopy, electrophysiology, Western blot, immunohistochemistry\",\n      \"pmids\": [\"19251977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which β2 recruits or retains synaptic components unresolved\", \"Whether partial NMJ phenotype occurs with hypomorphic alleles not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Comprehensive genotype–phenotype analysis across 39 families showed that missense mutations cluster in the N-terminal LN domain while truncating mutations are distributed throughout, linking domain-specific effects to disease severity and implicating the LN domain in polymerization-critical intermolecular interactions.\",\n      \"evidence\": \"Mutation screening of 39 families, domain mapping, clinical phenotype correlation\",\n      \"pmids\": [\"20556798\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct biochemical demonstration that LN-domain missense mutations impair polymerization in vitro\", \"Functional impact of individual missense variants not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The R246Q missense mutation was shown to impair laminin-521 secretion from podocytes, and transgenic overexpression rescued glomerular function in a dose-dependent manner, establishing that secretion competence of laminin β2 is the rate-limiting step in GBM assembly.\",\n      \"evidence\": \"Transgenic mouse rescue of Lamb2-null with R246Q rat LAMB2, in vitro secretion assays, proteinuria quantification, electron microscopy\",\n      \"pmids\": [\"21511833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular fate of misfolded R246Q protein (degradation pathway) not characterized\", \"Whether other missense mutations share the same secretion-defect mechanism unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Lamb2/Lamc3 compound-null mice exhibited cobblestone lissencephaly with fractured pial basement membrane and radial glial disorganization, revealing that LAMB2-containing laminins are essential for cortical development and that haploinsufficiency alone perturbs laminar organization.\",\n      \"evidence\": \"Conditional/constitutive knockout mice, histology, immunofluorescence for dystroglycan and Cajal-Retzius markers\",\n      \"pmids\": [\"22961762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of Lamb2 versus Lamc3 not fully separated\", \"Whether dystroglycan is the sole receptor mediating this phenotype not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"An ENU-induced hypomorphic Lamb2 allele caused viable nephrotic syndrome in mice, confirming that partial loss of function produces a milder phenotype and providing a model for the clinical spectrum of Pierson syndrome.\",\n      \"evidence\": \"ENU mutagenesis screen, whole-genome sequencing, renal phenotyping\",\n      \"pmids\": [\"24293254\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific molecular defect of the ENU allele (secretion vs. folding vs. polymerization) not defined\", \"NMJ and ocular phenotypes of this allele not characterized\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The lncRNA Airn was shown to bind Igf2bp2 and facilitate LAMB2 translation in podocytes, revealing a post-transcriptional regulatory axis controlling laminin β2 protein levels under metabolic stress.\",\n      \"evidence\": \"RNA immunoprecipitation, RNA pull-down, lncRNA knockdown/overexpression, Western blot for LAMB2 in podocyte cell lines under high glucose\",\n      \"pmids\": [\"32437062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of Igf2bp2 to LAMB2 mRNA not demonstrated\", \"In vivo relevance in kidney not tested\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A minigene splicing assay proved that the intronic LAMB2 variant c.2885-9C>A causes aberrant splicing, and absent glomerular β2 expression in patient tissue confirmed pathogenic loss of function, extending the mutational spectrum to deep-intronic variants.\",\n      \"evidence\": \"Minigene assay, Sanger sequencing, immunohistochemistry of patient kidney biopsy\",\n      \"pmids\": [\"33982833\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effect on NMJ and eye not assessed in this patient\", \"Whether this splice variant produces any residual protein not quantified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"LAMB2 was identified as a cargo of exosomes secreted by oligodendrocyte precursor cells in a Connexin 47-dependent manner, and exosomal LAMB2 promoted OPC proliferation via cyclin D1 activation, revealing an unexpected paracrine signaling role beyond structural matrix function.\",\n      \"evidence\": \"Mass spectrometry of exosome contents, siRNA knockdown of Cx47, exogenous LAMB2 rescue, cell cycle analysis\",\n      \"pmids\": [\"35596050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor on OPCs mediating LAMB2 signaling not identified\", \"In vivo relevance to myelination not demonstrated\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Under hypoxia, ROCK1-mediated phosphorylation of Caveolin1 at Y14 drives LAMB2 sorting into extracellular vesicles via Rab11 activation, and EV-associated LAMB2 activates AKT signaling in recipient gastric cancer cells to promote peritoneal metastasis, establishing a non-canonical oncogenic role for LAMB2.\",\n      \"evidence\": \"Proteomic analysis of EVs, Caveolin1 Y14 mutagenesis, Rab11 activation assays, AKT pathway readouts, peritoneal metastasis mouse model\",\n      \"pmids\": [\"39138263\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-surface receptor on recipient cells that transduces LAMB2 signal to AKT not identified\", \"Whether LAMB2 is the sole effector or acts with other EV cargo not resolved\", \"Single cancer type studied\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The receptor(s) that mediate LAMB2 paracrine/EV signaling (AKT, cyclin D1 activation) in non-matrix contexts remain unidentified, and whether the structural and signaling functions of LAMB2 are mechanistically separable is unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No receptor identified for EV-associated LAMB2 signaling\", \"Structural basis of LN domain polymerization not resolved at atomic level\", \"Whether LAMB2 translation regulation by Airn/Igf2bp2 operates in tissues beyond podocytes is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3, 4, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 3, 4, 5]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 9, 10]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 3, 4, 5, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 5]}\n    ],\n    \"complexes\": [\n      \"laminin-521 (α5β2γ1)\"\n    ],\n    \"partners\": [\n      \"LAMA5\",\n      \"LAMC1\",\n      \"LAMC3\",\n      \"IGF2BP2\",\n      \"CAV1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"LAMB2 encodes laminin subunit beta-2, a basement membrane glycoprotein that assembles into heterotrimeric laminin isoforms (e.g., laminin-521) and is essential for structural integrity at the neuromuscular junction, glomerular filtration barrier, and cortical pial surface [PMID:2922051, PMID:21511833, PMID:22961762]. At the neuromuscular junction, laminin beta-2 concentrates in the synaptic cleft where it organizes pre- and postsynaptic architecture; its complete absence causes a congenital myasthenic syndrome with reduced quantal content, simplified postsynaptic folds, and Schwann cell invasion of the synaptic space [PMID:19251977]. In the kidney, disease-causing missense mutations—clustered in the N-terminal LN domain—impair laminin-521 secretion from podocytes, resulting in glomerular basement membrane defects and nephrotic syndrome (Pierson syndrome), with severity inversely proportional to residual secretion [PMID:21511833, PMID:20556798]. LAMB2 translation in podocytes is post-transcriptionally regulated by the lncRNA Airn via Igf2bp2, and under hypoxia LAMB2 is sorted into extracellular vesicles through ROCK1-phosphorylated Caveolin-1/Rab11 to activate AKT signaling in recipient cells [PMID:32437062, PMID:39138263].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Chromosomal localization of LAMB2 provided the first genomic context for the gene, initially assigned to 1q25–q31 and later corrected to 3p21, establishing it as a distinct locus from LAMB1.\",\n      \"evidence\": \"cDNA cloning with somatic cell hybrid and FISH mapping across two independent studies\",\n      \"pmids\": [\"3234037\", \"7795887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Promoter and regulatory elements were not characterized\", \"Evolutionary relationship to LAMB1 was only later addressed by physical mapping\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Identification of S-laminin (LAMB2) as a synaptic cleft-specific laminin variant answered the question of how the neuromuscular junction basal lamina is molecularly distinct from extrasynaptic basement membrane.\",\n      \"evidence\": \"Protein purification, molecular cloning, and immunolocalization at neuromuscular junctions in frog and rat\",\n      \"pmids\": [\"2922051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of selective synaptic targeting was unknown\", \"Functional consequences of loss at the NMJ were not yet tested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Tissue-specific expression profiling revealed that LAMB2 and LAMB1 have non-overlapping expression in many tissues (e.g., LAMB2 in glomeruli and brain, LAMB1 in striated muscle), establishing that the two beta chains fulfill distinct biological roles.\",\n      \"evidence\": \"Northern blot and in situ hybridization across human fetal tissues\",\n      \"pmids\": [\"7795887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of tissue-specific expression not yet tested by loss-of-function\", \"Whether compensatory upregulation of LAMB1 occurs in LAMB2-deficient tissues was unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Analysis of a human patient with truncating LAMB2 mutations resolved the functional requirement for laminin beta-2 at the NMJ, showing that complete loss causes a synaptic congenital myasthenic syndrome with ultrastructural disruption and reduced quantal content.\",\n      \"evidence\": \"Human muscle biopsy with electron microscopy, electrophysiology (endplate potential and miniature endplate potential recording), Western blot, and mutation analysis\",\n      \"pmids\": [\"19251977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NMJ defects are secondary to developmental mis-patterning or ongoing structural maintenance failure was unclear\", \"Mechanism by which laminin beta-2 organizes the postsynaptic apparatus was not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Systematic genotype-phenotype correlation across 39 families established that missense mutations cluster in the LN domain—the intermolecular interaction domain—and cause milder phenotypes, while truncating mutations throughout the gene cause severe Pierson syndrome, mapping functional criticality to the LN domain.\",\n      \"evidence\": \"Mutational analysis of 39 families with genotype-phenotype correlation\",\n      \"pmids\": [\"20556798\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural basis for why specific LN domain residues are critical\", \"Contribution of other domains (e.g., coiled-coil) to function not systematically tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The molecular mechanism of the R246Q missense mutation was resolved: it impairs secretion of laminin-521 from podocytes, and dose-dependent transgenic expression demonstrated that increasing mutant protein levels rescues glomerular permselectivity, establishing secretion efficiency as the rate-limiting step.\",\n      \"evidence\": \"In vitro laminin secretion assay, three transgenic mouse lines with graded expression, proteinuria measurement, immunolocalization, and electron microscopy\",\n      \"pmids\": [\"21511833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the secretion defect reflects misfolding or specific ER retention was not determined\", \"Therapeutic strategies to boost secretion were not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Double knockout of Lamb2 and Lamc3 demonstrated a dose-dependent role for beta-2/gamma-3-containing laminins in maintaining the pial basement membrane, with loss causing cobblestone lissencephaly, disrupted Cajal-Retzius cell distribution, and radial glial detachment.\",\n      \"evidence\": \"Lamb2/Lamc3 single and double knockout mice with cortical histology, immunofluorescence for dystroglycan, Cajal-Retzius, and radial glial markers\",\n      \"pmids\": [\"22961762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contributions of LAMB2 versus LAMC3 to pial BM integrity were partially confounded by the double-knockout design\", \"Downstream signaling through dystroglycan was correlative rather than causally tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of the lncRNA Airn/Igf2bp2 axis as a post-transcriptional regulator of LAMB2 translation in podocytes revealed how glomerular laminin beta-2 levels are maintained, with downregulation under high-glucose conditions linking LAMB2 to diabetic nephropathy pathogenesis.\",\n      \"evidence\": \"RNA immunoprecipitation, RNA pull-down, lncRNA overexpression/knockdown, Western blot in podocyte cell lines\",\n      \"pmids\": [\"32437062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of the Airn-Igf2bp2-LAMB2 axis in animal models was not performed\", \"Whether this regulatory axis operates outside podocytes was not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that LAMB2 is an abundant cargo of OPC-derived exosomes downstream of connexin 47 signaling, and that exogenous LAMB2 promotes OPC proliferation via cyclin D1 activation, extended LAMB2 function to paracrine signaling in glial biology.\",\n      \"evidence\": \"Mass spectrometry of exosome content, nanoparticle tracking, exogenous LAMB2 treatment with cell cycle analysis in OPCs\",\n      \"pmids\": [\"35596050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The receptor or integrin through which extracellular LAMB2 activates cyclin D1 in OPCs was not identified\", \"In vivo relevance for myelination or remyelination was not demonstrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The ROCK1–phospho-Caveolin1(Y14)–Rab11 axis was identified as the mechanism by which hypoxic cancer cells sort LAMB2 into extracellular vesicles that activate AKT-dependent peritoneal metastasis, establishing a pathological gain-of-function role for LAMB2 in cancer.\",\n      \"evidence\": \"Proteomics, co-IP, phosphorylation assays, EV isolation, and in vivo peritoneal metastasis models in gastric cancer\",\n      \"pmids\": [\"39138263\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The receptor on recipient cells through which EV-associated LAMB2 activates AKT was not identified\", \"Generalizability beyond gastric cancer was not addressed\", \"Single-lab finding awaiting independent replication\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for LN domain missense mutation pathogenicity, the receptor(s) mediating extracellular LAMB2 signaling on OPCs and cancer cells, whether ER chaperone-assisted strategies can rescue secretion-deficient mutants therapeutically, and the relative individual contributions of LAMB2 versus LAMC3 to pial basement membrane integrity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of laminin beta-2 LN domain\", \"No identified receptor for paracrine/EV-mediated LAMB2 signaling\", \"No therapeutic rescue of secretion-deficient mutants demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 5, 8]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 5, 7, 8]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 7, 11, 12]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [11, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 5, 7, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [11, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 7, 12]}\n    ],\n    \"complexes\": [\n      \"Laminin-521 heterotrimer\"\n    ],\n    \"partners\": [\n      \"LAMA5\",\n      \"LAMC1\",\n      \"LAMC3\",\n      \"IGF2BP2\",\n      \"CAV1\",\n      \"RAB11A\",\n      \"ROCK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}